Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05337189

A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China

Sponsor: Creative Biosciences (Guangzhou) Co., Ltd.

View on ClinicalTrials.gov

Summary

The primary objective of this study is to assess the safety and effectiveness of Human Multigene Methylation Detection Kit (Fluorescent PCR Method) for help diagnose bladder cancer by comparing with clinical standard method (includes medical imaging (MRI, CT, etc.), cystoscopy, pathological examination).

Official title: A Multicenter, Single-blind, Observational Clinical Trial of URISAFE

Key Details

Gender

All

Age Range

Any - Any

Study Type

OBSERVATIONAL

Enrollment

482

Start Date

2022-03-09

Completion Date

2025-04-30

Last Updated

2025-02-13

Healthy Volunteers

Yes

Interventions

DIAGNOSTIC_TEST

Urine DNA methylation analysis

Urine specimen will be collected by the subject for the detection of Human Multigene Methylation Detection Kit (Fluorescent PCR Method)

PROCEDURE

medical imaging and/or cystoscopy and/or pathological examination

Subjects will undergo medical imaging and/or cystoscopy and/or pathological examination

Locations (1)

Beijing Cancer Hospital

Beijing, Beijing Municipality, China